Ewing Tumor-Associated Antigen 1 (ETAA1) Peptide
ETAA1
Reactivité: Humain, Rat
Hôte: Synthetic
BP
-
- Antigène Tous les produits ETAA1
- ETAA1 (Ewing Tumor-Associated Antigen 1 (ETAA1))
- Origine
- Humain, Rat
- Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-ETAA1 Antibody reactivity.
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- ETAA1 (Ewing Tumor-Associated Antigen 1 (ETAA1))
- Synonymes
- ETAA16 Peptide, ETAA1 Peptide, 5730466H23Rik Peptide, AA672646 Peptide, etaa1 Peptide, MGC145507 Peptide, MGC81344 Peptide, RGD1560957 Peptide, zgc:171518 Peptide, ETAA1, ATR kinase activator Peptide, Ewing tumor-associated antigen 1 Peptide, Ewing tumor associated antigen 1 Peptide, ETAA1, ATR kinase activator L homeolog Peptide, ETAA1 Peptide, Etaa1 Peptide, etaa1 Peptide, etaa1.L Peptide
- Sujet
- ETAA16, Ewing's tumor-associated antigen 1, Ewing's tumor-associated antigen 16
- ID gène
- 54465
- UniProt
- Q9NY74
-
Vous êtes ici:
